| Financial Year |
March 31 2023 |
| Monetary Funds |
4,030,841,851.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
825,455,488.97 |
| Advances to Suppliers |
40,660,166.86 |
| Other Receivables |
8,430,134.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,791,886,698.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
64,714,721.22 |
| Total Current Assets |
6,858,639,747.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,832,939.31 |
| Investment Properties |
-- |
| Fixed Assetes |
2,286,655,000.25 |
| Under-construction Projects |
927,548,186.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
542,007,382.33 |
| R&D expenses |
46,758,371.60 |
| Goodwill |
110,848,785.42 |
| Long-Term Deferred and Prepaid Expenses |
5,773,283.90 |
| Deferred Income Tax Assets |
33,774,264.48 |
| Other Non-Current Assets |
7,436,775.92 |
| Sub-Total of Non-Current Assets |
4,096,263,848.67 |
| Total Assets |
10,954,903,596.51 |
| Short-Term Loans |
401,433,416.68 |
| Trading Financial liabilities |
2,033,315.25 |
| Notes Payable |
296,702,500.00 |
| Accounts Payable |
801,286,807.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
118,291,923.95 |
| Taxes Payable |
140,561,535.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
341,237,854.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
200,091,500.00 |
| Other Current Liabilities |
4,357,833.89 |
| Sub-Total of Current Liabilities |
2,396,630,530.67 |
| Long-term Loans |
157,975,147.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
106,539,694.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
423,701,322.00 |
| Total Liabilities |
2,820,331,852.67 |
| Paid-In Capital(Or Share Stock) |
899,545,728.00 |
| Capital Surplus |
4,486,661,272.61 |
| Surplus Reserve |
231,827,389.50 |
| LESS:Treasury Stock |
126,828,569.06 |
| Undistributed Profits |
2,563,587,091.66 |
| Minority Stockholder's Interest |
73,683,615.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,060,888,128.40 |
| Owner's Equity（Stockholder's Equity） |
8,134,571,743.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,954,903,596.51 |
